Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: Questioning the autoimmunity hypothesis

Muscle and Nerve

Volumn 37, Issue 1, 2008, Pages 130-135

  Smyth, Shane ^a   Menkes, Daniel L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Autoimmunity; Glomerulonephritis; Neuropathy; Plasma exchange; Proteinuria

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; ELECTROMYOGRAPHY; FOLLOW UP; HUMAN; KIDNEY BIOPSY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; TENDON REFLEX; WEAKNESS;

ADULT; AGE OF ONSET; AUTOIMMUNE DISEASES; DISEASE PROGRESSION; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; METHOTREXATE; PERIPHERAL NERVES; PLASMAPHERESIS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; TREATMENT OUTCOME;

EID: 37749051423     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20841     Document Type: Article

References (30)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1991;41:617-618.
2. Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, et al. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2003;8:282-284.
3. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495-499.
4. Brady HR, O'Meara YM, Brenner BM. Glomerular diseases. In: Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL, editors. Harrison's principles of internal medicine, 16th ed. New York: McGraw-Hill; 2005. p 1674-1694.
5. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-2506.
6. Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999;122:1383-1390.
7. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. Neurology 1993;43:817-824.'
8. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997;48:321-328.
9. Hassan K, Gross B, Simri W, Rubinchik I, Cohen H, Jacobi J, et al. The presence of erythropoietin receptors in the human peripheral nervous system. Clin Nephrol 2004;61:127-129.
10. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-615.
11. Hoke A. Neuroprotection in the peripheral nervous system. Arch Neurol 2006;63:1681-1685.
12. Kohli A, Tandon P, Kher V. Chronic inflammatory demyelinating polyradiculoneuropathy with membranous glomerulonephritis: report of one case. Clin Neurol Neurosurg 1992;94:31-33.
13. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005;352:1343-1356.
14. Latov NL, Gorson KG, Brannagan TH, Freeman RL, Apostolski S, Berger AR. Diagnosis and treatment of chronic immune mediated neuropathies. J Clin Neuromuscul Dis 2006;8:141-157.
15. Levy JB, Pusey CD. Nephrotoxicity of intravenous immunoglobulin. Q J Med 2000;93:751-755.
16. Lopate GL, Pestronk A, Al-Lozi M. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Arch Neurol 2005;62:249-254.
17. Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, et al. Effect of angiotensin-converting-enzymc (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998;352:1978-1981.
18. Mobbs RJ, Tuck RR, Hurley B. Chronic inflammatory demyelinating polyneuropathy associated with membranous glomerulonephritis: case report. J Clin Neurosci 2000;7:454-455.
19. Macdougall IC. The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. Nephrol Dial Transplant 1999;14:1836-1841.
20. Menkes DL, Hood DC, Ballesteros RA, Williams DA. Root stimulation aids in the detection of acquired demyelinating polyneuropathies. Muscle Nerve 1998;21:298-308.
21. Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney - a two-edged sword. Semin Arthritis Rheum 2004;34:593-601.
22. Panjwani M, Truong LD, Eknoyan G. Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. Am J Kidney Dis 1996;27:279-283.
23. Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003;325:349-362.
24. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, non-albuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998;128:982-988.
25. Rodriguez-Iturbe B, Garcia R, Rubio L, Zabala J, Moros G, Torres R. Acute glomerulonephritis in the Guillain-Barré-Strohl syndrome. Report of nine cases. Ann Intern Med 1973;78:391-395.
26. Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005;128:1911-1920.
27. Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG. Demyelinating polyneuropathy in diabetes mellitus. Arch Neurol 2002;59:758-765.
28. Watkins PJ, Thomas PK. Diabetes mellitus and the nervous system. J Neurol Neurosurg Psychiatry 1998;65:620-632.
29. Witte AS, Burke JF. Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy. Neurology 1987;37:342-345.
30. Wu AD, Russell JA, Bouthout BA. Chronic inflammatory demyelinating polyneuropathy and membranous glomerulonephropathy: report of two cases. J Clin Neuromuscul Dis 2001;3:70-74.